Companies: 10,795·Total market cap: $144.5T
Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SIONNASDAQHealthcare● Active
$34.08
$-1.29(-3.64%)
Market Cap$1.5B
P/E Ratio—
52W High$48.445
52W Low$13.51
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Sionna Therapeutics, Inc. (SION) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SION · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.93sion eps ttm · sion earnings per shareEarnings history
PE Ratio (TTM)—sion pe ratio ttm · sion price to earningsPE Ratio deep dive
Revenue (TTM)0.00sion revenue ttm · sion annual revenueFull revenue history
Dividend YieldNo Dividenddoes sion pay dividends · sion dividend yieldDividend history
Shares Outstanding40.0Msion shares outstanding · sion floatShares outstanding history
Next EarningsAug 10, 2026Est.sion earnings date · sion next earningsEarnings history

Explore Sionna Therapeutics, Inc. Data

sion stock data · financials
Market Cap$1.5Bsion market cap · sion valuation
Analyst Forecast$54 · Buy
DividendsNo Dividenddoes sionna therapeutics, inc. pay dividends · sion dividend yield
Revenue—sionna therapeutics, inc. annual revenue · sion revenue
EarningsEPS $-1.88-34.29%sion earnings · sion eps
PE Ratio—sion pe ratio · sion price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
sionna therapeutics, inc. revenue · sion revenue 2025
FY 2025Net Income-$75.3M▼ 22.01% YoY
202320242025
sionna therapeutics, inc. net income · sion profit 2025
FY 2025EPS$-1.88▼ 34.29% YoY
202320242025
sion eps · sionna therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$85.6MEPS: $-1.93View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis sion a buy · sion analyst rating
Strong Buy
0
Buy
5
Hold
1
Sell
1
Strong Sell
0
12-Month Price Target
$50.00Low
$34.08Current
$54.00Avg Target58.44% upside
$58.00High
sion price target · sion 12 month forecast

Total: 7 · Buy rate: 71.4%

The SION analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $54.00, representing +58.44% upside from the current price of $34.08.

Stock Performance

Full History
1D-3.62%
1W-6.60%
1M-22.93%
3M-5.12%
YTD-17.14%
1Y+107.11%
5Y+36.36%

About Sionna Therapeutics, Inc.

CEOMichael Cloonan
IPO DateFeb 7, 2025
Employees41
CountryUS
Websitesionnatx.com

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosi…

BiotechnologyHealthcareNASDAQUS

what is sionna therapeutics, inc. · sion stock overview · sionna therapeutics, inc. company profile · who is sionna therapeutics, inc. ceo · sion NASDAQ · sionna therapeutics, inc. headquarters · sionna therapeutics, inc. business segments

About Stock Overview & Key Data

Sionna Therapeutics, Inc. (SION) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 7, 2025. As of the latest trading session, SION stock price is $34.08, with a market capitalization of $1.5B. The stock has returned +107.11% over the past 12 months and -17.14% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Sionna Therapeutics, Inc. stock is Buy, with an average 12-month price target of $54.00. In fiscal year 2025, Sionna Therapeutics, Inc. reported revenue of — and net income of -$75.3M. For detailed data — including Sionna Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Sionna Therapeutics, Inc. (SION) stock price is $34.08. The stock is traded on NASDAQ under the ticker symbol SION. The 52-week range is $13.51 – $48.45.

SION stock priceSION quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice